104 related articles for article (PubMed ID: 1550771)
21. Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapy.
Ho AD; Grossmann M; Knauf W; Martin H; Trümper L; Zwingers T; Sonnen R; Pralle H; Hunstein W
Leukemia; 1989 Oct; 3(10):718-23. PubMed ID: 2506398
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia.
Musolino C; Di Cesare E; Alonci A; Allegra A; Orlando A; Grosso P; Squadrito G
Acta Haematol; 1991; 85(2):57-61. PubMed ID: 1902614
[TBL] [Abstract][Full Text] [Related]
24. Soluble CD8 in patients with rheumatic diseases.
Symons JA; Wood NC; di Giovine FS; Duff GW
Clin Exp Immunol; 1990 Jun; 80(3):354-9. PubMed ID: 2115417
[TBL] [Abstract][Full Text] [Related]
25. Lower concentration of serum soluble CD8 in severe Hashimoto's disease.
Yamamoto N; Watanabe M; Matsuzuka F; Miyauchi A; Iwatani Y
Clin Exp Immunol; 2004 Sep; 137(3):601-5. PubMed ID: 15320913
[TBL] [Abstract][Full Text] [Related]
26. [Soluble lymphocyte antigens in hematological diseases].
Yoneyama A; Higashihara M; Nakahara K
Rinsho Ketsueki; 1995 Apr; 36(4):286-92. PubMed ID: 7783331
[TBL] [Abstract][Full Text] [Related]
27. [Levels of soluble CD4 and soluble CD8 in patients with sarcoidosis].
Sato S; Ina Y; Takada K; Sato T; Ito S; Sahashi K; Yamamoto M; Morishita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Feb; 32(2):117-24. PubMed ID: 8164397
[TBL] [Abstract][Full Text] [Related]
28. Modifications of general parameters of immune activation in the sera of Sicilian patients with Boutonneuse fever.
Mansueto S; Vitale G; Mocciaro C; Gambino G; Colletti P; Mansueto P; Spinelli A; Affronti M; Chifari N; Arcoleo F; Milano S; Cillari E
Clin Exp Immunol; 1998 Mar; 111(3):555-8. PubMed ID: 9528898
[TBL] [Abstract][Full Text] [Related]
29. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C Virus and related changes in immunological parameters in non Hodgkin's lymphoma patients.
el-Din HM; Attia MA; Hamza MR; Khaled HM; Thoraya MA; Eisa SA
Egypt J Immunol; 2004; 11(1):55-64. PubMed ID: 15724387
[TBL] [Abstract][Full Text] [Related]
31. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of serial measurement of the serum levels of soluble interleukin-2 receptor and soluble CD8 in malignant lymphoma.
Motokura T; Kobayashi Y; Fujita A; Nakamura Y; Taniguchi T; Uchimaru K; Asano S
Leuk Lymphoma; 1995 Jan; 16(3-4):355-62. PubMed ID: 7719243
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic and prognostic implications of peripheral blood lymphopenia in patients with Hodgkin's disease.
Ayoub JP; Palmer JL; Huh Y; Cabanillas F; Younes A
Leuk Lymphoma; 1999 Aug; 34(5-6):519-27. PubMed ID: 10492075
[TBL] [Abstract][Full Text] [Related]
34. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome.
Sawada S; Sugai S; Iijima S; Takei M; Paredes E; Hayama T; Nishinarita S; Hosokawa Y; Horie T; Obara T
Am J Med; 1992 Feb; 92(2):134-40. PubMed ID: 1543196
[TBL] [Abstract][Full Text] [Related]
35. Elevated in vivo and in vitro secretion of CD8-alpha molecules in patients with systemic lupus erythematosus.
Linker-Israeli M; Hyun S; Ozeri-Chen T; Wallace DJ; Banks K; Klinenberg JR
J Immunol; 1994 Mar; 152(6):3158-67. PubMed ID: 8144910
[TBL] [Abstract][Full Text] [Related]
36. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
37. Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia.
Ho AD; Grossman M; Trümper L; Pezzutto A; Pralle H; Boedewadt-Radzun S; Papendick U; Göd B; Zwingers T; Hunstein W
Blood; 1990 Mar; 75(5):1119-24. PubMed ID: 2106352
[TBL] [Abstract][Full Text] [Related]
38. Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab.
Siemiątkowska A; Bryl M; Kosicka-Noworzyń K; Tvrdoň J; Gołda-Gocka I; Główka FK
Cancer Immunol Immunother; 2023 Jun; 72(6):1853-1863. PubMed ID: 36688998
[TBL] [Abstract][Full Text] [Related]
39. [Expression and significance of serum sICAM-1 and sCD4 & sCD8 in patients with nasopharyngeal carcinoma].
Wang L; Shu M; Wei Q; Xiang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Nov; 16(11):596-8. PubMed ID: 15515547
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte subpopulations and concentrations of soluble CD8 and CD4 antigen after anaerobic training.
Weiss C; Kinscherf R; Roth S; Friedmann B; Fischbach T; Reus J; Dröge W; Bärtsch P
Int J Sports Med; 1995 Feb; 16(2):117-21. PubMed ID: 7751074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
